Jazz Pharma reports record 2022 revenue of $3.7B, up 18% YoY; guides 2023 revenue $3.675-3.875B

Jazz Pharmaceuticals plc

2022-FY EPS reported -$3.58 revenue$3,659,374,000

Record 2022 total revenue $3.7B (+18% YoY); 2023 revenue guidance $3.675-3.875B (3% growth at midpoint).
Xywav became largest product in Q4, annualizing >$1B; more narcolepsy patients on Xywav than Xyrem.
Cash from operations $1.3B in 2022; delevered balance sheet to 2.9x adjusted net leverage.
Pipeline progress: positive zanidatamab pivotal trial in BTC; Phase 2 suvecaltamide in Parkinson's tremor enrolled.
FDA approved Rylaze sBLA for MWF IM dosing; Epidyolex launched in all five key EU markets.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Jazz Pharmaceuticals plc reported full year 2023 results: revenue $3,675 to $3,875 million. Guidance initiated.

Period: full year 2023
Revenue: $3,675 to $3,875 million
Guidance: initiated
Result: guidance update

Exact text from the filing

2023 total revenue guidance of $3,675 to $3,875 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Jazz Pharmaceuticals plc reported full year and fourth quarter ended December 31, 2022 results: revenue $3.7 billion.

Period: full year and fourth quarter ended December 31, 2022
Revenue: $3.7 billion
Result: reported results

Exact text from the filing

Strong Execution Drove Record Revenues in 2022 of $3.7 billion, an increase of 18% over 2021

View on SEC.gov

18 earnings releases filed in the last 30 days. Browse all earnings releases →

Jazz Pharmaceuticals plc filing history →

Source: SEC EDGAR

accession 0001232524-23-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.